VRX Silica lines up buyers and approvals for Arrowsmith North

VRX Silica Limited (ASX:VRX) is no longer pitching Arrowsmith North as merely a promising deposit. Its annual report describes a project with State approvals, a completed adjacent farm purchase, six binding offtake agreements covering about 960,000 tonnes of silica sand a year and a reported post-tax ungeared NPV8 of A$179.2 million. The timetable, however, still runs through several gates: amended environmental approvals, project finance, a final investment decision and construction.

Arrowsmith North builds its commercial case

The project has a Proved and Probable Ore Reserve of 221 million tonnes at up to 99.5% SiO₂, with planned output ramping from 0.8 million to 1 million tonnes a year in its first two years before reaching a stated 2 million tonne annual capacity. The six four-year offtake agreements cover AFS20, AFS35 and AFS55 foundry sand, as well as Mid West Premium glass sand, with buyers across South Korea, Japan, Taiwan, the Philippines and China. Pricing assumptions remain aligned with the updated feasibility study at US$38 to US$43 per dry metric tonne.

The May 2026 updated BFS puts the project’s post-tax ungeared NPV8 at A$179.2 million over a 25-year mine life, while the underlying resource exceeds 100 years. Capital expenditure has risen by about A$8.3 million from the previous study, partly reflecting higher equipment, steel, concrete and construction labour costs. The report says the revised estimate includes a 10% contingency and indicates a payback period of about 4.6 years. Those figures remain feasibility-study estimates rather than operating results.

Arramall purchase changes the approval equation

VRX completed its purchase of the 2,091-hectare Arramall farm after year-end for A$4.25 million. The cleared freehold site is intended to host the processing plant and associated infrastructure, with access to Brand Highway and a shorter route to Geraldton Port. VRX says the relocation should reduce native vegetation clearing and improve the environmental configuration, but it also triggered applications to amend existing State and Commonwealth approvals.

Those amendments had not been finalised by the reporting date. The company expects decisions on the State applications and Commonwealth offset strategy in the first half of FY27, while targeting trial shipments in late 2027 and sustained production in early 2028. The offtake agreements themselves remain subject to conditions including financing, final permitting, logistics and port arrangements, commissioning and an initial trial shipment.

Funding remains the immediate financial test

VRX reported a FY26 net loss of A$4.27 million and operating cash outflows of A$3.49 million. It held A$4.12 million in cash at 30 June, but subsequently drew A$2.06 million net of fees and capitalised interest from a facility secured against Arramall, with the principal repayable within 12 months. Directors said the company is pursuing a debt and equity financing package for Arrowsmith North and working capital, while acknowledging that further equity or cost reductions may be required if that effort is unsuccessful.

Funding activity has nevertheless widened the shareholder base. The company raised A$2.1 million through a November placement and A$2.86 million through its June entitlement offer, followed after year-end by a A$4.55 million placement to institutional and foreign investors, including Nebari and Sparta Invest. The associated options and the later CEO incentive package add another layer to the capital structure as VRX moves from exploration expenditure toward construction funding.

Muchea offers scale beyond the first mine

Muchea remains the longer-dated second act. VRX reports a 208 million tonne resource grading 99.6% SiO₂ and says the Western Australian Government supports a land swap designed to move mining onto a smaller replacement lease while increasing access to high-grade sand in an area it considers less environmentally constrained. The company plans further environmental surveys, regulatory referrals and an update to the 2019 BFS in FY27.

For shareholders, the tension is now quite specific: VRX has a defined customer base and a sizeable feasibility-study value, but it is still pre-production and dependent on approvals, financing and execution. The next meaningful evidence will come not from another resource headline, but from whether the amended approvals and project finance arrive in time to preserve the late-2027 shipment target.